That higher UPF3A expression enhances the aggressiveness of triple-negative and human epidermal growth factor receptor 2 (HER2)-enriched breast cancers and worsens metastasis free survival, according to the gene expression profile of breast tumors retrieved from the GEO database [154]. This evidence concerns the gene ERBB2 and breast carcinoma.